Immunai Raises $60M to Decode the Immune System with Machine

Immunai Raises $60M to Decode the Immune System with Machine Learning and AI


AlleyWatch
The immune system at its core is a complex system of cells, organs, and tissues. These components work in unison to fight infection in the form of microbes. Developing an understanding of how this intricate system works is critical in ensuring that society as a whole has adequate immune health to combat disease and infection. 
Immunai has built the largest database for immunology in the world using machine learning and AI to map the entire immune system at a  granular and specific level.  This data can be leveraged by the healthcare industry to provide better therapeutics that get to market faster.  This understanding will also allow biotech companies and pharmaceutical manufacturers to radically personalize therapeutics in the future.   Immunai is initially focused on the oncology market but the offering is versatile can be applied to things like autoimmune disorders and infectious diseases like COVID-19.

Related Keywords

New York , United States , Danny Wells , Ansu Satpathy , Dexcel Pharma , Parker Institute , Duquesne Family Office , Cofounder Noam Solomon , Schusterman Family Investments , Catalio Capital Management , Viola Ventures , Annotated Multi Omic Immune Cell Atlas , Dan Littman , Multiomic Immune Cell Atlas , Noam Solomon , Immunai , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , டேனி கிணறுகள் , அன்சு சத்பதி , பார்க்கர் நிறுவனம் , ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம் , வயல முயற்சிகள் , டான் லிட்மேன் , நோம் சாலமன் ,

© 2025 Vimarsana